Automated Multiplex CRISPR-CasLambda17 Vector Foundry Cap Rate 2026

Underwrite GMP Class A/B continuous synthetic sub-140aa ultra-compact CasLambda17 non-viral synthetic lipid nanoparticle (LNP) packaging cleanroom suites, $700/sqft base lease rates, and exit cap rates.

Underwriting Assumptions

CasLambda17 Cleanroom Footprint (sqft)

NNN Base Lease Rate ($/sqft/yr)

Turnkey GMP CasLambda17 Foundry Acquisition ($)

Target Exit Capitalization Rate (%)

Projected Economics

Net Operating Income (NOI)

Going-In Capitalization Rate

Stabilized Institutional Valuation